Ticker Scorecard - ACRV Basics Company: Acrivon Therapeutics, Inc. IPO Date: November 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $172.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.94% Avg Daily Range (30 D): $0.26 | 4.47% Avg Daily Range (90 D): $0.24 | 3.69% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 61 Institutional Trades Total Inst.Trades: 17 Avg Inst. Trade: $2.53M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.57M Avg Closing Trade (30 D): $1.1M Avg Closing Trade (90 D): $1.1M Avg Closing Volume: 253.42K     News Sep 14, 2024 @ 7:10 AM Acrivon Therapeutics Reports Positive Endometrial ... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Jul 5, 2024 @ 1:31 PM AstraZeneca's (AZN) Tagrisso Gets EU Nod for First... Source: N/A Jul 2, 2024 @ 4:12 PM SpringWorks (SWTX) Completes NDA Submission for Mi... Source: Zacks Equity Research Jul 2, 2024 @ 3:00 PM AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for ... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.59 $-.52 $-.73 Diluted EPS $-.59 $-.52 $-.73 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -22.44M $ -18.8M $ -16.49M Operating Income / Loss $ -25.14M $ -21.44M $ -17.67M Cost of Revenue $ $ $ Net Cash Flow $ -2.82M $ 21.4M $ -11.41M PE Ratio